Pharma Pulse 5/31/24: OpenAI Says Russia & China Used Its AI in Covert Campaigns, FDA Diversity-Related Documents for Clinical Trials & more

An Overview of FDA Diversity-Related Documents for Clinical Trials

There is significant potential in decentralized models and digital health technology to expand diversity in clinical trials.

Going Back to the Basics: An Asthma Review

A review of asthma guidelines, pharmacotherapy, and the role of the pharmacist.

OpenAI Says Russia and China Used Its A.I. in Covert Campaigns

Iran and an Israeli company also exploited the tools in online influence efforts, but none gained much traction, an OpenAI report said.

GoodRx Named One of the 2024 TIME100 Most Influential Companies

GoodRx, the leading destination for prescription savings in the U.S., was named to the fourth-annual TIME100 Most Influential Companies list, which highlights companies making an extraordinary impact around the world. This is the second time GoodRx has received this honor for helping Americans get the medications they need at a price they can afford.

AION Labs on LinkedIn:

AION Labs’ CEO Mati Gill spoke with Michael Hollan to discuss how leveraging #AI and computational biology can improve drug discovery and development for the benefit of patients and what makes Israel's #biotechspace so attractive for global investment.
Read the article in Pharmaceutical Executive:https://lnkd.in/dk2VnisK

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs